ALKERMES (ALKS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALKS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALKS | Independent Director | 74 | ["Oncologic surgeon","Clinical researcher","Consulting professor at Stanford University Center for Innovation in Global Health","Chief Medical Editor at NBC News","Clinical professor of Otolaryngology at the University of Pennsylvania","Senior Vice President Corporate Communications at Johnson & Johnson","Practiced as an Otolaryngologist at UC San Francisco and California Pacific Medical Center","Medical Editor for ABC News","Board member of Lyra Therapeutics, Inc.","Board member of Future Health ESG Corp.","Board member of Axonics, Inc.","Kellogg Fellow","Fellow in the American College of Surgeons","Co-founder of the Stanford University-NBC News Global Media Fellowship"] | ["Audit and Risk","Financial Operating","Audit and Risk Committee","Financial Operating Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Snyderman is an oncologic surgeon and clinical researcher. She was a consulting professor at Stanford University Center for Innovation in Global Health from July 2019 to July 2022, served as Chief Medical Editor at NBC News from 2006 until 2015 and was a clinical professor of Otolaryngology at the University of Pennsylvania from August 2003 to December 2015. Dr. Snyderman was Senior Vice President Corporate Communications at Johnson & Johnson, a publicly-traded pharmaceutical company, from January 2003 to September 2006. She practiced as an Otolaryngologist at UC San Francisco and the California Pacific Medical Center from July 1994 to June 2003 and acted as Medical Editor for ABC News from 1987 until May 2003. Dr. Snyderman has served on the board of directors of Lyra Therapeutics, Inc., a formerly publicly-traded clinical-stage biotechnology company, since October 2020, and previously served on the boards of directors of Future Health ESG Corp., a publicly-traded special purpose acquisition company, from September 2021 to March 2024, and Axonics, Inc., a publicly-traded medical device company, from April 2019 to November 2024. Dr. Snyderman is a Kellogg Fellow, a Fellow in the American College of Surgeons and co-founder of the Stanford University-NBC News Global Media Fellowship. During Dr. Snyderman s tenure as a medical journalist at NBC News and ABC News, she received Emmy Awards, Edward R. Murrow Awards, a Columbia University DuPont Award, and a Gracie Award for her reporting. Dr. Snyderman attended medical school at the University of Nebraska and completed residencies in Pediatrics and Otolaryngology at the University of Pittsburgh.